Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART
Public ClinicalTrials.gov record NCT01751646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 50,000 IU Every 4 Weeks to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroidism in Youth With HIV Infection Being Treated With Tenofovir-Containing Combination Antiretroviral Therapy (cART)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 48 week randomized double-blind, placebo-controlled prospective cohort study of adolescents and young adults with HIV infection in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) who are currently being treated with cART that includes tenofovir disoproxil fumarate (TDF) as one component of the regimen that includes at least three Food and Drug Administration (FDA)-approved antiretroviral (ARV) drugs for at least 180 days.
Study identification
- NCT ID
- NCT01751646
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Interventions
- Vitamin D3 50,000 IU Dietary Supplement
- Vitamin D3 placebo Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 16 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2012 (Type not available)
- Primary completion
- Jun 2016 (Actual)
- Completion
- Jun 2016 (Actual)
- Last update posted
- Mar 27, 2019
2012 – 2016
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hopsital of Los Angeles | Los Angeles | California | 90027 | — |
| University of Southern California - NICHD Westat Site | Los Angeles | California | 90033 | — |
| Childrens National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Children's Diagnostic and Treatment Center - NICHD Westat Site | Fort Lauderdale | Florida | 33316 | — |
| University of Miami School of Medicine | Miami | Florida | 33101 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Stroger Hospital and the CORE Center | Chicago | Illinois | 60612 | — |
| Tulane Medical Center | New Orleans | Louisiana | 70112 | — |
| Johns Hopkins University - NICHD Westat Site | Baltimore | Maryland | 21287 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Fenway Institute | Boston | Massachusetts | 02215 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| St. Jude Childrens Research Hospital | Memphis | Tennessee | 38105 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01751646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 27, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01751646 live on ClinicalTrials.gov.